Avidity Biosciences Inc is a biotechnology business based in the US. Avidity Biosciences Inc shares (RNA) are listed on the NASDAQ and all prices are listed in US Dollars. Avidity Biosciences Inc employs 125 staff and has a trailing 12-month revenue of around $8 million.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Active traders
| Latest market close | $15.61 |
|---|---|
| 52-week range | $10.89 - $29.25 |
| 50-day moving average | $19.65 |
| 200-day moving average | $17.44 |
| Wall St. target price | $38.29 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-2.91 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $15.61 from 2022-10-03
| 1 week (2022-09-27) | -6.53% |
|---|---|
| 1 month (2022-09-02) | -26.58% |
| 3 months (2022-07-05) | -8.66% |
| 6 months (2022-04-05) | -21.52% |
| 1 year (2021-10-05) | -30.25% |
|---|---|
| 2 years (2020-10-05) | -47.84% |
| 3 years (2019-10-01) | N/A |
| 5 years (2017-10-01) | N/A |
| Revenue TTM | $8 million |
|---|---|
| Gross profit TTM | $-91,856,000 |
| Return on assets TTM | -26.11% |
| Return on equity TTM | -46.25% |
| Profit margin | 0% |
| Book value | $7.19 |
| Market capitalisation | $851.2 million |
TTM: trailing 12 months
We're not expecting Avidity Biosciences Inc to pay a dividend over the next 12 months.
Over the last 12 months, Avidity Biosciences Inc's shares have ranged in value from as little as $10.89 up to $29.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Avidity Biosciences Inc's is 0.8758. This would suggest that Avidity Biosciences Inc's shares are less volatile than average (for this exchange).
Avidity Biosciences, Inc. , a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; AOC 1044 for the treatment of Duchenne Muscular Dystrophy; and AOC 1020 designed to treat facioscapulohumeral muscular dystrophy which are in preclinical stage. It also offers Lumizyme therapy for Pompe diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
Our list of 10 dividend stocks to watch in 2022.
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.